GO:0035873 lactate transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035873 lactate transmembrane transport describes the movement of lactate (2-hydroxypropanoate) across biological membranes, a process central to cellular metabolism, pH regulation and inter-organ metabolic communication.
• The SLC16A family of monocarboxylate transporters (MCTs), especially MCT1 (SLC16A1), MCT2 (SLC16A7), MCT3 (SLC16A8) and MCT4 (SLC16A3), are the principal proton-coupled lactate transporters in mammals.
• Lactate transport is not merely a waste-removal system; it supports the lactate shuttle between producer and consumer cells, including neurons, astrocytes, muscle and tumor cells.
• Dysregulated lactate transport is implicated in cancer progression, metabolic disorders and inflammatory diseases, making MCTs attractive drug targets.
• Structural and pharmacological studies have revealed how MCT1 can be inhibited by anti-cancer drug candidates, providing a template for selective modulator design.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the causal roles of lactate transporters in physiology and disease.
Description
Lactate transmembrane transport (GO:0035873) is the biological process by which lactate, the end product of anaerobic glycolysis, is moved across cell membranes. This process is essential for maintaining intracellular pH, recycling redox equivalents and distributing metabolic fuel between tissues. In mammals, lactate is transported primarily by members of the SLC16 gene family, which encode monocarboxylate transporters (MCTs) that couple lactate movement to proton gradients. The physiological importance of lactate transport extends from skeletal muscle and brain to immune cells and tumors, where it shapes energy metabolism, signaling and intercellular communication. Because lactate transport sits at the intersection of metabolism, pH homeostasis and cell signaling, it has become a focal point for researchers in cancer biology, neuroscience, immunology and exercise physiology. Understanding the molecular players and regulatory mechanisms of GO:0035873 is therefore critical for developing therapeutic strategies that target lactate flux.
lactate transmembrane transport At A Glance
| GO ID | GO:0035873 |
|---|---|
| GO term | lactate transmembrane transport |
| Ontology | biological_process |
| Synonym | lactate membrane transport |
| Definition | The process in which lactate is transported across a membrane. Lactate is 2-hydroxypropanoate, CH3-CHOH-COOH; L(+)-lactate is formed by anaerobic glycolysis in animal tissues, and DL-lactate is found in sour milk, molasses and certain fruit juices. |
| Major function | Facilitates lactate movement across cell membranes, supporting metabolic coupling, pH regulation and intercellular signaling. |
| Key transporters | SLC16A1 (MCT1), SLC16A7 (MCT2), SLC16A8 (MCT3), SLC16A3 (MCT4), and other SLC16 family members. |
| Coupled ions | Protons (H+) in most MCTs, though some isoforms may have different coupling. |
| Tissue distribution | Widely expressed; MCT1 ubiquitous, MCT2 enriched in brain and testis, MCT4 in glycolytic tissues. |
What Is GO:0035873?
GO:0035873 lactate transmembrane transport is defined as the process in which lactate is transported across a membrane. Lactate (2-hydroxypropanoate, CH3-CHOH-COOH) exists as L(+)-lactate, formed by anaerobic glycolysis in animal tissues, and DL-lactate, found in sour milk, molasses and certain fruit juices. This process typically involves proton-coupled monocarboxylate transporters that facilitate the movement of lactate down its concentration gradient or against it, depending on cellular context.
Why Is lactate transmembrane transport Important in Cell Biology?
Lactate transmembrane transport is fundamental to cellular and systemic metabolism because it enables the redistribution of lactate as a metabolic fuel and signaling molecule. It supports the lactate shuttle, where lactate produced by glycolytic cells is taken up by oxidative cells for energy production. This process is critical for brain function, muscle performance, immune responses and cancer metabolism. Moreover, lactate transport influences intracellular pH and redox balance, affecting cell proliferation and survival. Consequently, dysregulated lactate transport contributes to pathologies such as cancer, diabetes and inflammatory diseases, making it a prime target for therapeutic intervention.
• Supports the lactate shuttle between producer and consumer cells, a key metabolic communication mechanism.
• Regulates intracellular pH and redox homeostasis, which are vital for cell survival and function.
• Plays a central role in cancer metabolism, where tumor cells often rely on lactate export for survival and growth.
• Contributes to brain energy metabolism and neurotransmitter recycling, impacting neuronal function.
• Modulates immune cell function and inflammatory responses, as shown by lactate-driven histone lactylation.
• Influences muscle fatigue and exercise performance through sarcolemmal lactate transport.
• Is implicated in metabolic disorders such as diabetes and obesity.
• Provides a target for anti-cancer drugs that inhibit MCT1.
• Affects drug resistance and tumor microenvironment acidification.
• Serves as a model system for studying proton-coupled transport mechanisms.
What Happens During lactate transmembrane transport?
Lactate production and gradient formation
In simple terms: Cells make lactate when they break down sugar without enough oxygen, creating a concentration difference that drives transport.
Lactate is produced primarily through anaerobic glycolysis, where pyruvate is reduced to lactate by lactate dehydrogenase (LDH). This production creates an intracellular lactate concentration that can exceed extracellular levels, establishing a gradient for transport. In highly glycolytic cells, such as muscle fibers during exercise or tumor cells, lactate accumulates and must be exported to maintain glycolysis and pH balance.
Proton-coupled transport by MCTs
In simple terms: Special transporter proteins move lactate across the membrane together with a proton, like a revolving door that carries two passengers at once.
The SLC16 family members, particularly MCT1-4, mediate the proton-linked transport of lactate across the plasma membrane. These transporters facilitate the symport of one lactate anion with one proton, effectively moving lactic acid. The direction of transport depends on the transmembrane gradients of lactate and protons, allowing cells to either export or import lactate. Structural studies of MCT1 have revealed the molecular basis for substrate recognition and inhibition by anti-cancer drug candidates.
Lactate uptake and utilization
In simple terms: Some cells take up lactate from their surroundings and use it as fuel, like refueling a car at a gas station.
Oxidative tissues, such as cardiac muscle, slow-twitch skeletal muscle and neurons, can import lactate via MCTs and convert it back to pyruvate for entry into the tricarboxylic acid cycle. This lactate shuttle allows efficient distribution of energy substrates across tissues. In the brain, lactate transported between astrocytes and neurons supports neuronal activity and memory formation.
Regulation by cellular signaling and pH
In simple terms: The activity of lactate transporters can be turned up or down by cellular signals and changes in acidity.
Lactate transport is regulated at multiple levels, including transcriptional control of SLC16 genes, post-translational modifications and interaction with accessory proteins such as basigin (CD147). Intracellular pH and proton gradients directly influence transport direction and rate. Additionally, signaling pathways such as those involving AMPK and hypoxia-inducible factors (HIFs) modulate MCT expression to meet metabolic demands.
Lactate as a signaling molecule
In simple terms: Lactate is not just waste; it can act like a messenger that changes how cells behave.
Beyond its metabolic role, lactate transported across membranes can influence cell signaling, including the regulation of gene expression through histone lactylation. This epigenetic modification links lactate transport to inflammatory responses and immune cell function. In cancer, lactate exported via MCT4 can acidify the tumor microenvironment, promoting invasion and immune evasion.
Key Genes Involved in GO:0035873 lactate transmembrane transport
The following genes encode proteins directly involved in lactate transmembrane transport or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC16A1 (MCT1) | Primary proton-coupled lactate transporter; facilitates lactate import/export in many tissues | Target for anti-cancer drugs; structural studies reveal inhibition mechanisms |
| SLC16A7 (MCT2) | High-affinity lactate transporter, enriched in neurons and testis | Key for brain lactate utilization and neuronal function |
| SLC16A8 (MCT3) | Lactate transporter in retinal pigment epithelium | Role in retinal metabolism and vision |
| SLC16A3 (MCT4) | Low-affinity, high-capacity lactate exporter in glycolytic cells | Important for tumor lactate efflux and microenvironment acidification |
| SLC16A11 | Lactate transporter associated with type 2 diabetes risk | Metabolic disease susceptibility |
| SLC16A13 | Lactate transporter in liver and pancreas | Potential role in glucose homeostasis |
| BSG (CD147) | Accessory protein required for proper trafficking and function of MCT1 and MCT4 | Chaperone for MCTs; target for modulating lactate transport |
| LDHA | Lactate dehydrogenase A; converts pyruvate to lactate | Produces lactate for transport; target in cancer metabolism |
| LDHB | Lactate dehydrogenase B; converts lactate to pyruvate | Facilitates lactate utilization in oxidative tissues |
| HIF1A | Hypoxia-inducible factor 1-alpha; upregulates MCT4 and LDHA under hypoxia | Regulates lactate transport in tumors and ischemic tissues |
| EPAS1 (HIF2A) | Hypoxia-inducible factor 2-alpha; regulates MCT expression | Implicated in cancer and metabolic adaptation |
| MYC | Oncogene that promotes glycolysis and lactate production | Links lactate transport to cancer progression |
| AMPK | Energy sensor that regulates MCT expression and activity | Coordinates lactate transport with cellular energy status |
| TMEM94 (ERMA) | Endoplasmic reticulum Mg2+ transporter; not directly lactate transport but related to ion homeostasis | Potential indirect effects on cellular metabolism |
| TMPRSS11B | Transmembrane protease that modulates lactate transport through SLC16A1 | Functional link to pancreatic ductal adenocarcinoma phenotype |
| PKM | Pyruvate kinase M; produces pyruvate for lactate generation | Regulates glycolytic flux and lactate production |
| GPR81 (HCAR1) | Lactate receptor; mediates signaling effects of extracellular lactate | Links lactate transport to signaling pathways |
How Is lactate transmembrane transport Regulated?
Lactate transmembrane transport is regulated at multiple levels. Transcriptional regulation of SLC16 genes is controlled by hypoxia-inducible factors (HIFs), which upregulate MCT4 and LDHA under low oxygen conditions. The energy sensor AMPK can also influence MCT expression and activity to match metabolic demand. Post-translational modifications and interaction with accessory proteins such as basigin (CD147) are required for proper trafficking and function of MCT1 and MCT4. Additionally, intracellular pH and proton gradients directly affect transport direction and rate. In inflammatory contexts, microbial metabolites can promote histone lactylation, linking lactate transport to epigenetic regulation. These regulatory mechanisms ensure that lactate flux is finely tuned to cellular and systemic needs.
lactate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC16A1 (MCT1) | Cancer, metabolic disorders | Knockout and point-mutation models to study inhibitor binding and transport kinetics |
| SLC16A3 (MCT4) | Cancer, tumor microenvironment acidification | Overexpression and knockout in cancer cell lines to assess lactate export and invasion |
| SLC16A7 (MCT2) | Neurological disorders, brain metabolism | Neuron-specific knockout in mice to study lactate utilization |
| SLC16A11 | Type 2 diabetes | Knock-in of risk variants in cell models to assess lactate transport and glucose metabolism |
| TMPRSS11B | Pancreatic ductal adenocarcinoma | Knockout and overexpression in PDAC cell lines to study SLC16A1 modulation |
Cancer metabolism and tumor microenvironment
Many cancer cells exhibit increased glycolysis and rely on lactate export to maintain intracellular pH and support growth. MCT4 (SLC16A3) is often upregulated in hypoxic tumor regions, where it exports lactate and acidifies the microenvironment, promoting invasion and immune evasion. MCT1 (SLC16A1) can be expressed in oxidative tumor cells that import lactate for energy production. Inhibitors of MCT1 have shown anti-cancer activity in preclinical models, and structural studies have elucidated their binding mechanisms. In pancreatic ductal adenocarcinoma, TMPRSS11B modulates lactate transport through SLC16A1, contributing to phenotype heterogeneity.
Inflammatory bowel disease and immune regulation
Lactate transport influences immune cell function and inflammatory responses. A recent study showed that microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease. This suggests that lactate transported into cells can act as a substrate for epigenetic modifications that modulate immune responses. Therefore, dysregulated lactate transport may contribute to chronic inflammation and autoimmune conditions.
Neurological disorders and brain metabolism
In the brain, lactate transport between astrocytes and neurons is essential for neuronal energy supply and function. MCT2 (SLC16A7) is the primary neuronal lactate transporter, and its dysfunction has been implicated in conditions such as ischemia and neurodegeneration. Disrupted lactate shuttling may contribute to cognitive impairment and neuronal death, making lactate transporters potential therapeutic targets for neurological disorders.
Metabolic disorders
Genetic variants in SLC16A11 are associated with increased risk of type 2 diabetes, highlighting the role of lactate transport in systemic glucose homeostasis. Additionally, exercise-induced lactate transport in skeletal muscle is critical for performance, and alterations in MCT expression have been linked to insulin resistance. Thus, lactate transport is a key player in metabolic health and disease.
From lactate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC16A1 affect lactate transport and cell proliferation? | CRISPR knockout of SLC16A1 in cancer cell lines |
| How do point mutations in SLC16A1 alter substrate specificity or inhibitor sensitivity? | CRISPR point-mutation knock-in of specific residues in SLC16A1 |
| What is the effect of MCT4 overexpression on tumor microenvironment acidification? | CRISPR-mediated overexpression of SLC16A3 in cancer cells |
| Can tagged MCT1 be used to track its localization and interactions? | Knock-in of epitope tags (e.g., FLAG, GFP) at the endogenous SLC16A1 locus |
| Does TMPRSS11B regulate lactate transport through SLC16A1 in PDAC? | Knockout and overexpression of TMPRSS11B in pancreatic cancer cells |
| What is the role of SLC16A7 in neuronal lactate uptake? | Neuron-specific knockout or knock-in of SLC16A7 in mice |
How to Study the lactate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Assess necessity of SLC16A1 in lactate transport |
| CRISPR point mutation | Specific amino acid changes | Study inhibitor binding or substrate specificity |
| CRISPR knock-in | Tagged or mutant protein expression | Track localization or interactions of MCTs |
| CRISPR overexpression | Increased gene expression | Model MCT4-driven lactate export in cancer |
| Lactate flux assay | Rate of lactate transport | Measure transport activity in cells or vesicles |
| Cryo-EM | High-resolution protein structure | Determine MCT1 architecture and inhibitor binding |
| RNA-seq | Transcriptome-wide expression | Profile SLC16 genes in disease models |
| Proteomics | Protein abundance and modifications | Identify interacting partners of MCTs |
Genetic manipulation with CRISPR
CRISPR-Cas9 technology enables precise knockout, point mutation, knock-in and overexpression of genes involved in lactate transport, such as SLC16A1 and SLC16A3. These models allow researchers to dissect the causal roles of specific transporters in cellular metabolism and disease. For example, knockout of SLC16A1 can reveal its necessity for lactate uptake in cancer cells.
Metabolic assays and lactate flux measurements
Lactate transport can be measured using isotope-labeled lactate, extracellular acidification rate (ECAR) assays, or lactate biosensors. These methods quantify the rate and direction of lactate flux in live cells or tissues. Combining genetic models with metabolic assays provides functional validation of transporter roles.
Structural and biochemical approaches
Structural biology techniques such as cryo-EM and X-ray crystallography have elucidated the architecture of MCT1 and its interactions with inhibitors. Biochemical assays, including transport assays in proteoliposomes, can determine kinetic parameters and substrate specificity. These approaches inform drug design targeting lactate transporters.
Expression profiling and bioinformatics
RNA-seq and proteomics can profile the expression of SLC16 family members and related genes across tissues and conditions. Bioinformatics analyses of public datasets can reveal correlations between lactate transporter expression and disease outcomes. Such studies generate hypotheses that can be tested with CRISPR models.
How CRISPR Can Be Used to Study GO:0035873 lactate transmembrane transport
Knockout
CRISPR knockout of SLC16A1 or SLC16A3 eliminates lactate transport activity, allowing researchers to study the consequences for cell metabolism, proliferation and survival. For example, knockout of SLC16A1 in cancer cells reduces lactate uptake and inhibits growth under hypoxic conditions. Such models are essential for validating therapeutic targets.
Point Mutation
Point mutations introduced by CRISPR can mimic disease-associated variants or alter key residues in the transport pore. For instance, mutations in SLC16A1 can affect inhibitor sensitivity or substrate specificity, providing insights into structure-function relationships. These models are valuable for drug resistance studies.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous SLC16A1 locus enables real-time tracking of transporter localization and dynamics. Knock-in of disease-risk variants, such as those in SLC16A11, can model their functional impact on lactate transport and metabolism.
Overexpression
CRISPR-mediated overexpression of SLC16A3 (MCT4) or other transporters can mimic the high lactate efflux seen in glycolytic tumors. Overexpression models help study the effects of increased lactate transport on tumor microenvironment acidification and immune evasion.
How EDITGENE Supports lactate transmembrane transport Research
Researchers studying lactate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in lactate flux, metabolic reprogramming or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes such as SLC16A1, SLC16A3 and their regulators.
Contact EDITGENE today to design your custom CRISPR model for lactate transmembrane transport research.
Frequently Asked Questions About lactate transmembrane transport
What is lactate transmembrane transport?
Lactate transmembrane transport (GO:0035873) is the process by which lactate molecules are moved across cell membranes, typically by proton-coupled monocarboxylate transporters.
What genes are involved in lactate transmembrane transport?
Key genes include SLC16A1 (MCT1), SLC16A7 (MCT2), SLC16A8 (MCT3), SLC16A3 (MCT4) and accessory proteins like BSG (CD147).
Why is lactate transport important in cancer?
Cancer cells often rely on lactate export to maintain pH and support growth; MCT4 is upregulated in hypoxic tumors and contributes to microenvironment acidification.
How is lactate transported across the membrane?
Most lactate transport is mediated by monocarboxylate transporters (MCTs) that couple lactate movement to proton symport.
What is the role of MCT1 in lactate transport?
MCT1 (SLC16A1) is a ubiquitous proton-coupled transporter that facilitates lactate import or export depending on gradients, and is a target for anti-cancer drugs.
Can lactate transport be targeted therapeutically?
Yes, inhibitors of MCT1 have shown anti-cancer activity, and modulating lactate transport is being explored for inflammatory and metabolic diseases.
What diseases are associated with lactate transport dysfunction?
Dysregulated lactate transport is linked to cancer, type 2 diabetes, inflammatory bowel disease and neurological disorders.
How do researchers study lactate transmembrane transport?
Common methods include CRISPR knockout/knock-in models, lactate flux assays, structural biology and expression profiling.
What is the lactate shuttle?
The lactate shuttle describes the intercellular exchange of lactate between producer cells (e.g., glycolytic muscle) and consumer cells (e.g., neurons, cardiac muscle) via MCTs.
What CRISPR models are available for lactate transport research?
EDITGENE offers knockout, point mutation, knock-in, overexpression and library screening services for genes like SLC16A1 and SLC16A3.
Conclusion
Lactate transmembrane transport (GO:0035873) is a fundamental biological process that underpins metabolic communication, pH regulation and cell signaling. The SLC16 family of transporters, particularly MCT1-4, are central players whose dysfunction is implicated in cancer, metabolic and inflammatory diseases. Advances in structural biology and CRISPR-based models are accelerating our understanding of lactate transport mechanisms and enabling the development of targeted therapeutics. Continued research into this process promises to yield new insights into human health and disease.
References
- 1. Wang N et al.. 2021. Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates.. Cell 184(2):370-383.e13 PMID: 33333023
- 2. Baiskhanova D et al.. 2025. Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Functional Link to Phenotype Heterogeneity.. Int J Mol Sci 26(11) PMID: 40508207
- 3. Halestrap AP. 2013. The SLC16 gene family - structure, role and regulation in health and disease.. Mol Aspects Med 34(2-3):337-49 PMID: 23506875
- 4. Jiang Y et al.. 2026. Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.. Cell Metab 38(7):1443-1459.e6 PMID: 42134325
- 5. Roth DA. 1991. The sarcolemmal lactate transporter: transmembrane determinants of lactate flux.. Med Sci Sports Exerc 23(8):925-34 PMID: 1956266
- 6. Halestrap AP. 2013. Monocarboxylic acid transport.. Compr Physiol 3(4):1611-43 PMID: 24265240
- 7. Vishnu N et al.. 2024. ERMA (TMEM94) is a P-type ATPase transporter for Mg(2+) uptake in the endoplasmic reticulum.. Mol Cell 84(7):1321-1337.e11 PMID: 38513662
- 8. Hertz L et al.. 2005. Lactate transport and transporters: general principles and functional roles in brain cells.. J Neurosci Res 79(1-2):11-8 PMID: 15586354
